Experimental exposure to 1,1,1,3,3-pentafluoropropane (HFC-245fa): Uptake and disposition in humans

Toxicological Sciences

Volumn 113, Issue 2, 2009, Pages 326-336

  Ernstgård, Lena ^a   Andersen, Melvin ^a,b   Dekant, Wolfgang ^c   Sjögren, Bengt ^a   Johanson, Gunnar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Hamner Institute for Health Sciences   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

1,1,1,3,3 pentafluoropropane; Experimental exposure; HFC 245fa; Human; Inflammatory markers; Toxicokinetics

Indexed keywords

1,1,1,3,3 PENTAFLUOROPROPANE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMYLOID A PROTEIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE BB; CREATINE KINASE MM; D DIMER; FIBRINOGEN; FLUORINATED HYDROCARBON; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 6; PROPIONIC ACID DERIVATIVE; TRIFLUOROACETIC ACID; TRIFLUOROPROPIONIC ACID; UNCLASSIFIED DRUG; URATE;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; BLOOD SAMPLING; BREATH ANALYSIS; CAPILLARY BLOOD; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EXERCISE; EXPIRED AIR; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTOXICITY; NORMAL HUMAN; STEADY STATE; TOXICOKINETICS; URINALYSIS; VISUAL ANALOG SCALE; VOLUNTEER;

ADULT; ATMOSPHERE EXPOSURE CHAMBERS; BIOLOGICAL MARKERS; BREATH TESTS; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; INHALATION EXPOSURE; MALE; QUESTIONNAIRES; YOUNG ADULT;

EID: 75249106762     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp273     Document Type: Article

References (29)

1. Andersen, M.E., Sarangapani, R., Reitz, R.H., Gallavan, R.H., Dobrev, I.D., and Plotzke, K.P. (2001). Physiological modeling reveals novel pharmacokinetic behavior for inhaled octamethylcyclotetrasiloxane in rats. Toxicol. Sci. 60, 214-231.
2. Bayer, T. (2005). In Toxicity and biotransformation of 1,1,1,3,3-pentafluoropropane, 3,3,3-trifluoropropionic acid and 1,1,1,3-tetrachloropropane Ph. D. Thesis, Würzburg University, Würzburg, Germany.
3. Bayer, T., Amberg, A., Bertermann, R., Rusch, G.M., Anders, M.W., and Dekant, W. (2002). Biotransformation of 1,1,1,3,3-pentafluoropropane (HFC-245fa). Chem. Res. Toxicol. 15, 723-733.
4. Beliveau, M., Tardif, R., and Krishnan, K. (2003). Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicol. Appl. Pharmacol. 189, 221-232.
5. Danesh, J., Collins, R., Appleby, P., and Peto, R. (1998). Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279, 1477-1482.
6. Danesh, J., Lewington, S., Thompson, S.G., Lowe, G.D., Collins, R., Kostis, J.B., Wilson, A.C., Folsom, A.R., Wu, K., Benderly, M., et al. (2005). Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 294, 1799-1809.
7. Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P., Gallimore, J.R., and Pepys, M.B. (2000). Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 321, 199-204.
8. Ernstgård, L., Gullstrand, E., Löf, A., and Johanson, G. (2002). Are women more sensitive than men to 2-propanol and m-xylene vapours? Occup. Environ. Med. 59, 759-767.
9. Ernstgård, L., Iregren, A., Sjögren, B., and Johanson, G. (2006a). Acute effects of exposure to vapours of acetic acid in humans. Toxicol. Lett. 165, 22-30.
10. Ernstgård, L., Iregren, A., Sjögren, B., and Johanson, G. (2006b). Acute effects of exposure to vapours of dioxane in humans. Hum. Exp. Toxicol. 25, 723-729.
11. Ernstgård, L., Iregren, A., Sjögren, B., Svedberg, U., and Johanson, G. (2006c). Acute effects of exposure to hexanal vapors in humans. J. Occup. Environ. Med. 48, 573-580.
12. Ernstgård, L., Lind, B., Andersen, M.E., and Johanson, G. (2009). Liquid-air partition coefficients of 1,1-difluoroethane (HFC152a), 1,1,1-trifluoroethane (HFC143a), 1,1,1,2-tetrafluoroethane (HFC134a), 1,1,1,2,2-pentafluoroethane (HFC125) and 1,1,1,3,3-pentafluoropropane (HFC245fa). J. Appl. Toxicol. Advance Access published on September 2, 2009; doi: 10.1002/jat.1473.
13. Feig, D.I., Kang, D.H., and Johnson, R.J. (2008). Uric acid and cardiovascular risk. N. Engl. J. Med. 359, 1811-1821.
14. Gunnare, S., Ernstgård, L., Sjögren, B., and Johanson, G. (2006). Toxicokinetics of 1,1,1,2-tetrafluoroethane (HFC-134a) in male volunteers after experimental exposure. Toxicol. Lett. 167, 54-65.
15. Gunnare, S., Ernstgård, L., Sjögren, B., and Johanson, G. (2007). Experimental exposure to 1,1,1-trifluoroethane (HFC-143a): Uptake, disposition and acute effects in male volunteers. Toxicol. Lett. 172, 120-130.
16. Hagberg, S., and Lillienberg, L. (1999). In Kylmontörer. Yrkeshygienisk bedömning av kylmontörers exponering för kemiska produkter Report no. 71. Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenborg, Sweden. (In Swedish).
17. Hakooz, N., Ito, K., Rawden, H., Gill, H., Lemmers, L., Boobis, A.R., Edwards, R.J., Carlile, D.J., Lake, B.G., and Houston, J.B. (2006). Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance. Pharm. Res. 23, 533-539.
18. Iregren, A., Tesarz, M., and Wigaeus-Hjelm, E. (1993). Human experimental MIBK exposure: Effects on heart rate, performance, and symptoms. Environ. Res. 63, 101-108.
19. Kosaraju, A., and Vandewalle, K.S. (2009). A comparison of a refrigerant and a topical anesthetic gel as preinjection anesthetics: A clinical evaluation. J. Am. Dent. Assoc. 140, 68-72; quiz 112-113.
20. Lillienberg, L., Ahlborg, B., Ahlborg, G., Jr., Anundi, H., Blixt, P., Dahlman-Höglund, A., Edling, C., Godenius, P., Hagberg, M., Karlberg, C., et al. (2002). In Exponering för köldmedier och oljor och risk för influensa-liknande symptom, ledbesvär och luftvägssjukdomen fall kontroll studie Report no. 71. Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. (In Swedish).
21. Malmberg, P., Hedenström, H., and Fridriksson, H.V. (1987). Reference values for gas exchange during exercise in healthy nonsmoking and smoking men. Bull. Eur. Physiopathol. Respir. 23, 131-138.
22. Meulenberg, C.J., and Vijverberg, H.P. (2000). Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds. Toxicol. Appl. Pharmacol. 165, 206-216.
23. Nihlén, A., and Johanson, G. (1999). Physiologically based toxicokinetic modeling of inhaled ethyl tertiary-butyl ether in humans. Toxicol. Sci. 51, 184-194.
24. Nihlén, A., Löf, A., and Johanson, G. (1998). Controlled ethyl tert-butyl ether (ETBE) exposure of male volunteers. I. Toxicokinetics. Toxicol. Sci. 46, 1-10.
25. Pedersen, L.M., and Cohr, K.H. (1984). Biochemical pattern in experimental exposure of humans to white spirit. II. The effects of repetitive exposures. Acta Pharmacol. Toxicol. (Copenh) 55, 325-330.
26. Reddy, M.B., Andersen, M.E., Morrow, P.E., Dobrev, I.D., Varaprath, S., Plotzke, K.P., and Utell, M.J. (2003). Physiological modeling of inhalation kinetics of octamethylcyclotetrasiloxane in humans during rest and exercise. Toxicol. Sci. 72, 3-18.
27. Rusch, G.M., Coombs, D., and Hardy, C. (1999). The acute, genetic, developmental, and inhalation toxicology of 1,1,1,3,3-pentafluoropropane (HFC 245fa). Toxicol. Sci. 52, 289-301.
28. Sundblad, B.M., Larsson, B.M., Acevedo, F., Ernstgård, L., Johanson, G., Larsson, K., and Palmberg, L. (2004). Acute respiratory effects of exposure to ammonia on healthy persons. Scand. J. Work Environ. Health 30, 313-321.
29. Vgontzas, A.N., Bixler, E.O., Lin, H.M., Prolo, P., Trakada, G., and Chrousos, G.P. (2005). IL-6 and its circadian secretion in humans. Neuroimmunomodulation 12, 131-140.